References
1. Russell RJ, Brightling C. Pathogenesis of asthma: implications for precision medicine. Clin Sci (Lond) 2017;131:1723-1735.
2. Cockcroft DW, Davis BE, Blais CM. Comparison of methacholine and mannitol challenges: importance of method of methacholine inhalation. Allergy Asthma Clin Immunol 2020;16:14.
3. Cockcroft DW, Davis BE, Blais CM. Direct bronchoprovocation test methods: history 1945-2018. Expert Rev Respir Med 2019;13:279-289.
4. Lévesque V, Poirier C, Dubé BP. Dose omission to shorten methacholine challenge testing: clinical consequences of the use of a 10% fall in FEV(1) threshold. Allergy Asthma Clin Immunol 2018;14:88.
5. Asher M, Keil U, Anderson H, Beasley R, Crane J, Martinez F, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995;8:483-491.
6. Duhme H, Weiland SK, Rudolph P, Wienke A, Kramer A, Keil U. Asthma and allergies among children in West and East Germany: a comparison between Munster and Greifswald using the ISAAC phase I protocol. International Study of Asthma and Allergies in Childhood. Eur Respir J 1998;11:840-847.
7. Yavuz ST, Civelek E, Tuncer A, Sahiner UM, Sekerel BE. Predictive factors for airway hyperresponsiveness in children with respiratory symptoms. Ann Allergy Asthma Immunol 2011;106:365-370.
8. Brand PL, Baraldi E, Bisgaard H, Boner AL, Castro-Rodriguez JA, Custovic A, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008;32:1096-1110.
9. Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med 2019;200:e70-e88.
10. Merget R, Jörres RA, Heinze E, Haufs MG, Taeger D, Brüning T. Development of a 1-concentration-4-step dosimeter protocol for methacholine testing. Respir Med 2009;103:607-613.
11. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O’Byrne PM, Anderson SD, et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:53-83.
12. Park JS, Choi YJ, Suh DI, Jung S, Kim YH, Lee SY, et al. Profiles and characteristics of bronchial responsiveness in general 7-year-old children. Pediatr Pulmonol 2019;54:713-720.
13. Tham EH, Lee AJ, Bever HV. Aeroallergen sensitization and allergic disease phenotypes in Asia. Asian Pac J Allergy Immunol 2016;34:181-189.
14. Lee E, Kim YH, Cho HJ, Yoon J, Jung S, Yang SI, et al. Clinical phenotypes of bronchial hyperresponsiveness in school-aged children. Ann Allergy Asthma Immunol 2018;121:434-443 e432.
15. Jo EJ, Eom JS, Mok J, Kim MH, Lee K, Kim KU, et al. Patterns of sensitization to aeroallergens and their effect on airway hyper-responsiveness in Busan, Korea. Asian Pac J Allergy Immunol 2019 Jul 16. doi: 10.12932/AP-261118-0447.
16. Vincent M, Corazza F, Chasseur C, Bladt S, Romano M, Huygen K, et al. Relationship between mold exposure, specific IgE sensitization, and clinical asthma: A case-control study. Ann Allergy Asthma Immunol 2018;121:333-339.
17. Mosges R, Graute V, Christ H, Sieber HJ, Wahn U, Niggemann B. Safety of ultra-rush titration of sublingual immunotherapy in asthmatic children with tree-pollen allergy. Pediatr Allergy Immunol 2010;21:1135-1138.
18. Lee J, Song JU. Diagnostic comparison of methacholine and mannitol bronchial challenge tests for identifying bronchial hyperresponsiveness in asthma: a systematic review and meta-analysis. J Asthma 2020 Mar 16;1-9. doi: 10.1080/02770903.2020.1739704.
19. Jung S, Suh DI, Lee SY, Yoon J, Cho HJ, Kim YH, et al. Prevalence, Risk Factors and Cutoff Values for Bronchial Hyperresponsiveness to Provocholine in 7-Year-Old Children. Allergy Asthma Immunol Res 2018;10:466-477.
20. Fuchs O, Bahmer T, Rabe KF, von Mutius E. Asthma transition from childhood into adulthood. Lancet Respir Med 2017;5:224-234.
21. Gray L, Peat JK, Belousova E, Xuan W, Woolcock AJ. Family patterns of asthma, atopy and airway hyperresponsiveness: an epidemiological study. Clin Exp Allergy 2000;30:393-399.
22. Alharbi SA, Kobeisy SAN, AlKhater SA, Alharbi AS, Alqwaiee MM, Alotaibi FN, et al. Childhood Asthma Awareness in Saudi Arabia: Five-Year Follow-Up Study. J Asthma Allergy 2020;13:399-407.
23. Ciprandi G, Marseglia GL, Ricciardolo FLM, Tosca MA. Pragmatic Markers in the Management of Asthma: A Real-World-Based Approach. Children (Basel) 2020;7:48.
24. Castro-Rodriguez JA, Cifuentes L, Martinez FD. Predicting Asthma Using Clinical Indexes. Front Pediatr 2019;7:320.
25. Jackson DJ, Gern JE, Lemanske RF, Jr. Lessons learned from birth cohort studies conducted in diverse environments. J Allergy Clin Immunol 2017;139:379-386.
26. de Marco R, Marcon A, Jarvis D, Accordini S, Almar E, Bugiani M, et al. Prognostic factors of asthma severity: a 9-year international prospective cohort study. J Allergy Clin Immunol 2006;117:1249-1256.
27. Rassouli F, Tinschert P, Barata F, Steurer-Stey C, Fleisch E, Puhan MA, et al. Characteristics of Asthma-related Nocturnal Cough: A Potential New Digital Biomarker. J Asthma Allergy 2020;13:649-657.
28. Fukuhara A, Saito J, Birring SS, Sato S, Uematsu M, Suzuki Y, et al. Clinical Characteristics of Cough Frequency Patterns in Patients with and without Asthma. J Allergy Clin Immunol Pract 2020;8:654-661.
29. Ohwada A, Sato K. Heterogeneity of perception of symptoms in patients with asthma. J Thorac Dis 2019;11:5218-5227.
30. Francisco B, Ner Z, Ge B, Hewett J, König P. Sensitivity of different spirometric tests for detecting airway obstruction in childhood asthma. J Asthma 2015;52:505-511.
31. Ciprandi G, Gallo F, Cirillo I. FEF25-75 and Asthma in Clinical Practice. Iran J Allergy Asthma Immunol 2018;17:295-297.
32. Malerba M, Radaeli A, Olivini A, Damiani G, Ragnoli B, Sorbello V, et al. Association of FEF25-75% Impairment with Bronchial Hyperresponsiveness and Airway Inflammation in Subjects with Asthma-Like Symptoms. Respiration 2016;91:206-214.
33. Hardaker KM, Downie SR, Kermode JA, Farah CS, Brown NJ, Berend N, et al. Predictors of airway hyperresponsiveness differ between old and young patients with asthma. Chest 2011;139:1395-1401.
34. Harmanci K, Bakirtas A, Turktas I. Factors affecting bronchial hyperreactivity in asthmatic children. J Asthma 2008;45:730-734.
35. Lukic KZ, Coates AL. Does the FEF25-75 or the FEF75 have any value in assessing lung disease in children with cystic fibrosis or asthma? Pediatr Pulmonol 2015;50:863-868.
36. Quanjer PH, Weiner DJ, Pretto JJ, Brazzale DJ, Boros PW. Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making. Eur Respir J 2014;43:1051-1058.
37. Kim YH, Lee E, Cho HJ, Yang SI, Jung YH, Kim HY, et al. Association between menarche and increased bronchial hyper-responsiveness during puberty in female children and adolescents. Pediatr Pulmonol 2016;51:1040-1047.
38. Grönke L, Kanniess F, Holz O, Jörres RA, Magnussen H. The relationship between airway hyper-responsiveness, markers of inflammation and lung function depends on the duration of the asthmatic disease. Clin Exp Allergy 2002;32:57-63.
39. Caudri D, Wijga A, CM AS, Hoekstra M, Postma DS, Koppelman GH, et al. Predicting the long-term prognosis of children with symptoms suggestive of asthma at preschool age. J Allergy Clin Immunol 2009;124:903-910 e901-907.